Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages

Free Radical Biology and Medicine

Volumn 32, Issue 8, 2002, Pages 688-701

  Urata, Yoshishige ^a   Yamaguchi, Michiko ^b   Higashiyama, Yasuhito ^a   Ihara, Yoshito ^a   Goto, Shinji ^a   Kuwano, Michihiko ^c   Horiuchi, Seikoh ^d   Sumikawa, Koji ^b   Kondo, Takahito ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AGE; ANG; AP 1; CML; ERK1 2; Free radicals; RAW264.7 cells; ROS; VEGF

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; BOVINE SERUM ALBUMIN; DNA; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SODIUM BOROHYDRIDE; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIABETES MELLITUS; DNA BINDING; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STIMULATION; TRANSCRIPTION REGULATION; VASCULAR DISEASE;

ANIMALS; BLOTTING, NORTHERN; CATTLE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA PRIMERS; DNA, COMPLEMENTARY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL GROWTH FACTORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYMPHOKINES; MACROPHAGES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS (GENETICS); REACTIVE OXYGEN SPECIES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM ALBUMIN; TRANSCRIPTION FACTOR AP-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

BOVINAE;

EID: 0037090221     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00823-1     Document Type: Article

References (57)

1. ε-(carboxymethyl-)lysine as a degradation product of fructoselysine in glycated proteins
2. Involvement of glycation and oxidative stress in diabetic macroangiopathy
3. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from amadori product
4. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
5. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging
6. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes
7. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease
8. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: Role of glycoxidation and lipoxidation reactions in vascular tissue damage
9. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy
10. Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7
11. Galectin-3 expression in human atherosclerotic lesions
12. Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products
13. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
14. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
15. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
16. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
17. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
18. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
19. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
20. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion
21. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
22. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells
23. Anti-angiogenin activity of the peptides complementary to the receptor-binding site of angiogenin
24. Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus
25. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy
26. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations
27. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
28. Ras activation of NF-kappa B and superoxide
29. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-β1
30. Reactive oxygen species modulate angiotensin II-induced β-myosin heavy chain gene expression via ras/raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes
31. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
32. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins
33. Intracellular protein glycation in cultured retinal capillary pericyte endothelial cells exposed to high-glucose concentration
34. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
35. Analysis of RNA
36. Mobility shift DNA-binding assay using gel electrophoresis
37. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
38. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression
39. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells
40. Identification of regulatory elements of cloned genes with functional assays
41. Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells
42. Flow cytometric studies of oxidative product formation by neutrophils: An oxidative response to membrane stimulation
43. Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: Association with retinal photocoagulation
44. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
45. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells
46. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism
47. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling
48. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins
49. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
50. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress
51. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
52. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
53. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
54. Regulation of mammalian gene expression by free radicals
55. Redox regulation of fos and jun DNA-binding activity in vitro
56. Inhibition of angiogenesis on glycated collagen lattices
57. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF